Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Imaging hypoxia to improve radiotherapy outcome.

Horsman MR, Mortensen LS, Petersen JB, Busk M, Overgaard J.

Nat Rev Clin Oncol. 2012 Dec;9(12):674-87. doi: 10.1038/nrclinonc.2012.171. Epub 2012 Nov 13. Review.

PMID:
23149893
2.

The impact of hypoxia and its modification of the outcome of radiotherapy.

Horsman MR, Overgaard J.

J Radiat Res. 2016 Aug;57 Suppl 1:i90-i98. doi: 10.1093/jrr/rrw007. Epub 2016 Mar 16. Review.

3.

Hypoxia imaging markers and applications for radiation treatment planning.

Lin A, Hahn SM.

Semin Nucl Med. 2012 Sep;42(5):343-52. doi: 10.1053/j.semnuclmed.2012.04.002. Review.

PMID:
22840599
4.

Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.

Pettersen EO, Ebbesen P, Gieling RG, Williams KJ, Dubois L, Lambin P, Ward C, Meehan J, Kunkler IH, Langdon SP, Ree AH, Flatmark K, Lyng H, Calzada MJ, Peso LD, Landazuri MO, Görlach A, Flamm H, Kieninger J, Urban G, Weltin A, Singleton DC, Haider S, Buffa FM, Harris AL, Scozzafava A, Supuran CT, Moser I, Jobst G, Busk M, Toustrup K, Overgaard J, Alsner J, Pouyssegur J, Chiche J, Mazure N, Marchiq I, Parks S, Ahmed A, Ashcroft M, Pastorekova S, Cao Y, Rouschop KM, Wouters BG, Koritzinsky M, Mujcic H, Cojocari D.

J Enzyme Inhib Med Chem. 2015;30(5):689-721. doi: 10.3109/14756366.2014.966704. Epub 2014 Oct 27. Review.

PMID:
25347767
5.

Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.

Søvik A, Malinen E, Bruland ØS, Bentzen SM, Olsen DR.

Phys Med Biol. 2007 Jan 21;52(2):499-513. Epub 2006 Dec 29.

PMID:
17202629
6.

Imaging of hypoxia using PET and MRI.

Gaertner FC, Souvatzoglou M, Brix G, Beer AJ.

Curr Pharm Biotechnol. 2012 Mar;13(4):552-70. Review.

PMID:
22214501
7.

Hypoxia imaging and radiotherapy: bridging the resolution gap.

Grimes DR, Warren DR, Warren S.

Br J Radiol. 2017 Aug;90(1076):20160939. doi: 10.1259/bjr.20160939. Epub 2017 May 25. Review.

8.

Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy.

Bittner MI, Wiedenmann N, Bucher S, Hentschel M, Mix M, Weber WA, Grosu AL.

Radiother Oncol. 2013 Sep;108(3):511-6. doi: 10.1016/j.radonc.2013.06.012. Epub 2013 Jul 10.

PMID:
23849686
9.

Hypoxic sensitizer and cytotoxin for head and neck cancer.

Lee DJ, Moini M, Giuliano J, Westra WH.

Ann Acad Med Singapore. 1996 May;25(3):397-404. Review.

PMID:
8876907
10.

LET-painting increases tumour control probability in hypoxic tumours.

Bassler N, Toftegaard J, Lühr A, Sørensen BS, Scifoni E, Krämer M, Jäkel O, Mortensen LS, Overgaard J, Petersen JB.

Acta Oncol. 2014 Jan;53(1):25-32. doi: 10.3109/0284186X.2013.832835. Epub 2013 Sep 10.

PMID:
24020629
11.

Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions.

Wouters A, Pauwels B, Lardon F, Vermorken JB.

Oncologist. 2007 Jun;12(6):690-712. Review.

12.

Detection and specific targeting of hypoxic regions within solid tumors: current preclinical and clinical strategies.

Bache M, Kappler M, Said HM, Staab A, Vordermark D.

Curr Med Chem. 2008;15(4):322-38. Review.

PMID:
18288988
13.

Measuring hypoxia in solid tumours--is there a gold standard?

Olive PL, Banáth JP, Aquino-Parsons C.

Acta Oncol. 2001;40(8):917-23.

PMID:
11845955
14.

Adapting radiotherapy to hypoxic tumours.

Malinen E, Søvik A, Hristov D, Bruland ØS, Olsen DR.

Phys Med Biol. 2006 Oct 7;51(19):4903-21. Epub 2006 Sep 18.

PMID:
16985278
15.

Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D.

Int J Radiat Biol. 2006 Oct;82(10):699-757. Review.

PMID:
17118889
16.

Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response.

Jeong J, Shoghi KI, Deasy JO.

Phys Med Biol. 2013 Jul 21;58(14):4897-919. doi: 10.1088/0031-9155/58/14/4897. Epub 2013 Jun 21.

17.

Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.

Popple RA, Ove R, Shen S.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):921-7.

PMID:
12377346
18.

Hypoxia as a biomarker for radioresistant cancer stem cells.

Peitzsch C, Perrin R, Hill RP, Dubrovska A, Kurth I.

Int J Radiat Biol. 2014 Aug;90(8):636-52. doi: 10.3109/09553002.2014.916841. Epub 2014 Jun 25. Review.

PMID:
24844374
19.

Impact of nicotinamide on human tumour hypoxic fraction measured using the comet assay.

McLaren DB, Pickles T, Thomson T, Olive PL.

Radiother Oncol. 1997 Nov;45(2):175-82.

PMID:
9424009

Supplemental Content

Support Center